Literature DB >> 27507259

Anti-CCP status determines the power Doppler oscillation pattern in rheumatoid arthritis: a prospective study.

Ottar Gadeholt1, Tobias Wech2, Sebastian Schuh3, Eva Scharbatke3, Eva Ostermeier3, Hans-Peter Tony3, Marc Schmalzing3.   

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disease leading to joint destruction. Serologically, it can be differentiated according to rheumatoid factor (RF), anti-cyclic citrullinated peptide antibodies (anti-CCP), or both. This differentiation is prognostically and therapeutically relevant. No method has been described to separate the two forms phenotypically. We hypothesize that a differentiation is possible by evaluating oscillation patterns in power Doppler sonography (PDS). In a prospective study, 20 patients with anti-CCP-positive RA and 20 patients with anti-CCP-negative RA with active wrist synovitis were examined. A PDS scan was performed, and perfusion maxima (P max) and minima (P min) as well as the amplitude (ΔP) were determined by a blinded study member. The amplitude was standardized (sΔP) by dividing by P max, and the anti-CCP-positive and anti-CCP-negative patients as well as the RF-positive and RF-negative were compared to each other. In the ultrasonographic evaluation, we found a highly significant difference in sΔP between CCPp and CCPn patients (median 19.0 vs. 42.9 %, p < 0.0001). sΔP is independent of disease activity. The absolute amplitude ΔP did not differ between the groups. Also, in anti-CCP-positive patients there was a completely linear correlation between P max and P min, and this was far less marked in anti-CCP-negative patients. Anti-CCP-positive and anti-CCP-negative RA display different PDS oscillation patterns. This constitutes a nonserological parameter to differentiate between the two forms. The difference in PDS oscillation patterns suggests that the underlying pathological process differs between the forms.

Entities:  

Keywords:  Anti-CCP; Power Doppler sonography; Rheumatoid arthritis; Rheumatoid factor; Ultrasonography

Mesh:

Substances:

Year:  2016        PMID: 27507259     DOI: 10.1007/s00296-016-3548-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  15 in total

1.  STUDIES OF THE INCIDENCE AND SIGNIFICANCE OF ANTI-GAMMA GLOBULIN FACTORS IN THE AGING.

Authors:  S D LITWIN; J M SINGER
Journal:  Arthritis Rheum       Date:  1965-08

2.  2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovsky; Frederick Wolfe; Gillian Hawker
Journal:  Ann Rheum Dis       Date:  2010-09       Impact factor: 19.103

Review 3.  Pro musculoskeletal ultrasonography in rheumatoid arthritis.

Authors:  Sarah Ohrndorf; Marina Backhaus
Journal:  Clin Exp Rheumatol       Date:  2015-10-12       Impact factor: 4.473

4.  Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis.

Authors:  Marcin Szkudlarek; Michel Court-Payen; Søren Jacobsen; Mette Klarlund; Henrik S Thomsen; Mikkel Østergaard
Journal:  Arthritis Rheum       Date:  2003-04

5.  Power Doppler sonography and pulse-inversion harmonic imaging in evaluation of rheumatoid arthritis synovitis.

Authors:  Claudia Schueller-Weidekamm; Christian Krestan; Gerd Schueller; Theresa Kapral; Daniel Aletaha; Franz Kainberger
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

6.  The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.

Authors:  Annette H M van der Helm-van Mil; Kirsten N Verpoort; Ferdinand C Breedveld; Tom W J Huizinga; René E M Toes; René R P de Vries
Journal:  Arthritis Rheum       Date:  2006-04

7.  Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis.

Authors:  John D Isaacs; Stanley B Cohen; Paul Emery; Paul P Tak; Jianmei Wang; Guiyuan Lei; Sarah Williams; Preeti Lal; Simon J Read
Journal:  Ann Rheum Dis       Date:  2012-06-11       Impact factor: 19.103

8.  Rheumatoid Factor Is Associated With the Distribution of Hand Joint Destruction in Rheumatoid Arthritis.

Authors:  Chikashi Terao; Noriyuki Yamakawa; Koichiro Yano; Iris M Markusse; Katsunori Ikari; Shinji Yoshida; Moritoshi Furu; Motomu Hashimoto; Hiromu Ito; Takao Fujii; Koichiro Ohmura; Kosaku Murakami; Meiko Takahashi; Masahide Hamaguchi; Yasuharu Tabara; Atsuo Taniguchi; Shigeki Momohara; Soumya Raychaudhuri; Cornelia F Allaart; Hisashi Yamanaka; Tsuneyo Mimori; Fumihiko Matsuda
Journal:  Arthritis Rheumatol       Date:  2015-12       Impact factor: 10.995

9.  Angiogenic gene expression and vascular density are reflected in ultrasonographic features of synovitis in early Rheumatoid Arthritis: an observational study.

Authors:  Stephen Kelly; Michele Bombardieri; Frances Humby; Nora Ng; Alessandra Marrelli; Sudeh Riahi; Maria DiCicco; Arti Mahto; Lu Zou; Debasish Pyne; Rebecca E Hands; Costantino Pitzalis
Journal:  Arthritis Res Ther       Date:  2015-03-13       Impact factor: 5.156

Review 10.  Anti-CCP2 antibodies: an overview and perspective of the diagnostic abilities of this serological marker for early rheumatoid arthritis.

Authors:  Walther J van Venrooij; Albert J W Zendman
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

View more
  2 in total

1.  Diagnostic accuracy of anti-keratin antibody for rheumatoid arthritis: a meta-analysis.

Authors:  Xue-Ping Wang; Qian-Yao Cheng; Ming-Ming Gu; Rui-Xue Leng; Yin-Guang Fan; Bao-Zhu Li; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2019-02-27       Impact factor: 2.980

2.  Study on the evaluation of rheumatoid arthritis via doppler ultrasonography and anti-cyclic citrullinated peptide antibody analysis.

Authors:  Li-Na Shang; Gui-Xin Di; Feng-Ju Wei; Zheng Zhang
Journal:  Pak J Med Sci       Date:  2020 Mar-Apr       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.